Clinical Trial

PDN Post Market, Multicenter, Prospective, Global Clinical Study

Study acronym: PDN-PM
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this post-market study is to evaluate the real-world experience of Nevro's Spinal Cord Stimulation (SCS) therapy in patients with chronic, intractable leg pain due to painful diabetic neuropathy (PDN). This is a multicenter, prospective, observational global study, that will partner diabetes management teams with pain physicians to provide an interdisciplinary treatment regimen for PDN patients. Outcomes will be assessed via standardized assessments.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-03-25; most recent amendment 2026-06-24.
Status change: Recruiting → Active, Not Recruiting 2026-06-24
Status change: Not Yet Recruiting → Recruiting 2022-06-28
Trial Details
NCT Number NCT05301816
Lead Sponsor Nevro Corp
Conditions Diabetic Neuropathy, Painful
Enrollment 497 participants
Start Date 2022-07-05
Primary Completion 2027-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-26